Glenmark Readies Push For SGLT2i With Torrent Deal, More In Store

Glenmark is pressing ahead with plans to widen market opportunities for remogliflozin in India. Its co-marketing alliance with Torrent is potentially the first among similar deals anticipated for the novel sodium glucose co-transporter-2 (SGLT2) inhibitor in a competitive segment.

Diabetes
Glenmark has firmed up a deal with Torrent for remogliflozin

Glenmark Pharmaceuticals Ltd. has sealed a licensing deal with peer Torrent Pharmaceuticals Ltd. for its novel sodium glucose co-transporter-2 (SGLT2) inhibitor, remogliflozin etabonate, as it pursues rapid market expansion for the diabetes therapy in India.

This is potentially the first of such alliances as Glenmark seeks to shake up the SGLT2 inhibitor segment, emulating what...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip